Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0NIQ stock hub

LON/0NIQ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0NIQis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.6B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0NIQ

In the news

Latest news · LON/0NIQ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E33.9

P25 12.9P50 16.9P75 23.5

Trailing P/E82

P25 15.9P50 22.9P75 35.8

ROE6.2

P25 -54.2P50 2.1P75 13.7

ROIC5.3

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0NIQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

224

Groups with data

Currency

EUR

Showing 224 of 224 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Germany
Country code	UK
Employees	14,242
Employees Change	514%
Employees Change Percent	3.8
Enterprise value	EUR 15.9B
Exchange	London Stock Exchange
Financial currency	EUR
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	DE0007165607
Last refreshed	2026-05-10
Market cap	EUR 11.6B
Price	EUR 173
Price currency	EUR
Rev Per Employee	217,907.59x
Sector	Healthcare
Sic	3826
Symbol	lon/0NIQ
Website	https://www.sartorius.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.22%
EV Earnings	111.8x
EV/EBIT	31.65x
EV/EBITDA	19.53x
EV/FCF	41.02x
EV/Sales	5.17x
FCF yield	3.32%
Forward P/E	33.88x
P/B ratio	3.43x
P/E ratio	82.04x
P/S ratio	3.75x
PE Ratio10 Y	85x
PE Ratio3 Y	118.43x
PE Ratio5 Y	98.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.43%
EBITDA Margin	25.48%
FCF margin	12.47%
Gross margin	45.59%
Gross Profit	EUR 1.4B
Gross Profit Growth	3.93%
Gross Profit Growth Q	-3.83%
Gross Profit Growth3 Y	-8.47%
Gross Profit Growth5 Y	3.57%
Net Income	EUR 142M
Net Income Growth	70.08%
Net Income Growth Q	15.88%
Net Income Growth Quarters	7%
Net Income Growth Years	1%
Net Income Growth3 Y	-34%
Net Income Growth5 Y	-8.55%
Pretax Margin	9.8%
Profit Margin	4.57%
Profit Per Employee	EUR 9,969
Profitable Years	16
ROA	3.65
Roa5y	6.71
ROCE	7.53
ROE	6.18
Roe5y	18.01
ROIC	5.26
Roic5y	11.05

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	10.92%
Cagr1y	-7.2%
Cagr3y	-15.46%
Cagr5y	-14.87%
Div CAGR10	7.64%
Div CAGR3	-20.52%
Div CAGR5	-7.18%
EPS Growth Quarters	7
EPS Growth Years	1
FCF Growth	-37.78%
FCF Growth Q	76.23%
FCF Growth3 Y	34.56%
FCF Growth5 Y	4.82%
OCF Growth	-17.13%
OCF Growth Q	35.7%
OCF Growth10 Y	20.97%
OCF Growth3 Y	6.04%
OCF Growth5 Y	7.19%
Revenue Growth	3.2x
Revenue Growth Q	1.82x
Revenue Growth Quarters	6x
Revenue Growth Years	1x
Revenue Growth3 Y	-4.28x
Revenue Growth5 Y	6.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.36
Assets	EUR 8.6B
Cash	EUR 501M
Current Assets	EUR 1.7B
Current Liabilities	EUR 1.8B
Debt	EUR 3.8B
Debt EBITDA	EUR 4.56
Debt Equity	EUR 1.11
Debt FCF	EUR 9.7
Equity	EUR 3.4B
Interest Coverage	3.58
Liabilities	EUR 5.2B
Long Term Assets	EUR 7B
Long Term Liabilities	EUR 3.4B
Net Cash	EUR -3.3B
Net Cash By Market Cap	EUR -27.94
Net Debt EBITDA	EUR 4.12
Net Debt Equity	EUR 0.96
Net Debt FCF	EUR 8.41
Tangible Book Value	EUR -2.2B
WACC	9.89

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.91
Inventory Turnover	2.39
Net Working Capital	EUR 174.8M
Quick ratio	0.45
Working Capital	EUR -165.7M
Working Capital Turnover	EUR 12.71

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Dividend Growth	3.61%
Dividend Growth Years	0%
Dividend per share	EUR 0.63
Dividend Years	20
Dividend Yield	0.37%
Ex Div Date	2026-03-27
Last Dividend	EUR 0.63
Payout Frequency	Annual
Payout Ratio	62.42%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	181.97%
1Y total return	-7.19%
200-day SMA	178.1
3Y total return	-39.6%
50-day SMA	175.1
50-day SMA vs 200-day SMA	50under200
5Y total return	-55.29%
All Time High	827
All Time High Change	-79.11%
All Time High Date	2021-09-08
All Time Low	11.75
All Time Low Change	1,370.64%
All Time Low Date	2012-07-10
ATR	7.12
Beta	1.4
Ch YTD	-9.34
High	176
High52	208
High52 Date	2026-01-08
High52ch	-16.92%
Low	172.4
Low52	145.4
Low52 Date	2025-08-07
Low52ch	18.85%
Ma50ch	-1.33%
Price vs 200-day SMA	-2.99%
RSI	47.29
RSI Monthly	43.1
RSI Weekly	46.18
Sharpe ratio	-0.08x
Sortino ratio	0.04
Total Return	0.37%
Tr YTD	-8.94
Tr1m	3.23%
Tr1w	-1.03%
Tr3m	-6.19%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 509.8M
Operating Income Growth	24.55
Operating Income Growth Q	11.85
Operating Income Growth3 Y	-18.41
Operating Income Growth5 Y	-0.99
Operating margin	16.43

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	27,448,420%
Net Borrowing	-287,709,539.3
Shares Institutions	15.06%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 387M
Average Volume	187x
CAPEX	EUR -387.3M
Ch10y	171.6
Ch1m	3.23
Ch1w	-1.03
Ch1y	-7.59
Ch3m	-6.59
Ch3y	-40.27
Ch5y	-56.14
Ch6m	-1.26
Change	-2.59%
Change From Open	-1.71
Close	177.4
Days Gap	-0.9
Depreciation Amortization	278,194,190.8
Dollar Volume	18,144
Earnings Date	2026-04-23
EBIT	EUR 509.8M
EBITDA	EUR 790.7M
F Score	7
FCF	EUR 387M
FCF EV Yield	2.44x
Financing CF	-556,998,570
Fiscal Year End	December
Founded	1,870
Goodwill	3,014,635,431.8
Graham Number	48.86953
Graham Upside	-71.72
Income Tax	EUR 95.7M
Investing CF	-446,891,155
Is Primary Listing	0
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Last Split Date	2016-06-13
Last Split Type	Forward
Lynch Fair Value	EUR 10.53
Lynch Upside	-93.91
Ma150	184.1
Ma150ch	-6.14%
Ma20	177.2
Ma20ch	-2.51%
Net CF	-232,002,696
Next Earnings Date	2026-07-23
Open	175.8
P FCF Ratio	30.1
P OCF Ratio	15.05
Payment Date	2026-03-31
Position In Range	11.11
Ppne	2,130,140,531.1
Price Date	2026-05-08
Price EBITDA	EUR 14.73
Relative Volume	0.54x
Revenue	3,103,439,907x
Tax By Revenue	3.08x
Tax Rate	31.47%
Tr6m	-0.83%
Volume	105

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0NIQ dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$0.63 annual per share

Payout ratio

+62.4%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-7.2%

0 consecutive years of growth

Total shareholder yield

+0.4%

Next ex-dividend date: 2026-03-27

Performance

LON/0NIQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0NIQ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.1%

Share of float held by funds and institutions

Insider ownership

n/a

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

n/a

Negative means the company is buying back shares.

Technical

LON/0NIQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.3

Neutral momentum band

Price vs 200-day MA

-3.0%

50/200-day relationship not available

Beta (5Y)

1.40

More volatile than the market

Sharpe ratio

-0.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0NIQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0NIQ stock rating?

lon/0NIQ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0NIQ analysis?

The full report lives at /stocks/lon/0NIQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0NIQ?

The latest report frames lon/0NIQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0NIQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.